Christine McFarland

Associate Partner & Gene Therapy Biosafety Officer

Christine McFarland received her Ph.D. from Texas A&M University and worked for over a decade as a research scientist studying infectious diseases, including tuberculosis. She left the lab for a career in Biosafety in 2008 and served as Texas A&M's Biological Safety Officer and Executive Director of Biosafety until her retirement in June of 2021. She also served as the University's Responsible Official for their Select Agent Program for four years. Christine enjoys Pilates, traveling, and listening to true crime podcasts now that she has more free time. She remains interested in biosafety and is excited by any opportunity that allows her to be active and engaged in her chosen field.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.